5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer

Epigenetics

Volumn 6, Issue 11, 2011, Pages 1362-1372

  Saldova, Radka ^a   Dempsey, Eugene ^a   Pérez Garay, Marta ^b   Mariño, Karina ^a   Watson, Jenny A ^a   Blanco Fernández, Alfonso ^a   Struwe, Weston B ^a   Harvey, David J ^a   Madden, Stephen F ^c   Peracaula, Rosa ^b   McCann, Amanda ^a   Rudd, Pauline M ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF GIRONA   (Spain)

^c DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Core fucosylation; DNA methylation; Epigenetics; MGAT5; N glycosylation; Ovarian cancer; OVCAR3; Sialylation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; DNA METHYLTRANSFERASE; GLYCOPROTEIN;

ARTICLE; BIOSYNTHESIS; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CELL CYCLE; CELL SECRETION; DEMETHYLATION; DNA METHYLATION; EPIGENETICS; FUCOSYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; METASTASIS; MYELODYSPLASTIC SYNDROME; OVARIAN CANCER EPITHELIAL CELL; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN SECRETION; SIALYLATION; UPREGULATION;

EID: 81055154923     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.11.17977     Document Type: Article

References (39)

1. Dwek RA. Glycobiology: Toward Understanding the Function of Sugars. Chem Rev 1996; 96:683-720; PMID:11848770; DOI:10.1002/chin.199630329.
2. Spiro RG. Protein glycosylation: nature, distribution, enzymatic formation and disease implications of glycopeptide bonds. Glycobiology 2002; 12:43-56; PMID:12042244; DOI:10.1093/glycob/12.4.43R.
3. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996; 56:5309-18; PMID:8968075.
4. Marino K, Bones J, Kattla JJ, Rudd PM. A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol 2010; 6:713-23; PMID:20852609; DOI:10.1038/nchembio.437.
5. Campbell MP, Royle L, Radcliffe CM, Dwek RA, Rudd PM. GlycoBase and autoGU: tools for HPLCbased glycan analysis. Bioinformatics 2008; 24:1214-6; PMID:18344517; DOI:10.1093/bioinformatics/btn090.
6. Pierce A, Saldova R, Abd Hamid UM, Abrahams JL, McDermott EW, Evoy D, et al. Levels of specific glycans significantly distinguish lymph node-positive from lymph node-negative breast cancer patients. Glycobiology 2010; 20:1283-8; PMID:20581008; DOI:10.1093/glycob/cwq090.
7. Saldova R, Fan Y, Fitzpatrick JM, Watson RW, Rudd PM. Core fucosylation and {alpha}2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology 2010; 21:195-205; PMID:20861084; DOI:10.1093/glycob/cwq147.
8. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007; 17:1344-56; PMID:17884841; DOI:10.1093/glycob/cwm100.
9. Saldova R, Wormald MR, Dwek RA, Rudd PM. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis Markers 2008; 25:219-32; PMID:19126966.
10. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33:245-54; PMID:12610534; DOI:10.1038/ng1089.
11. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010; 28:1057-68; PMID:20944598; DOI:10.1038/nbt.1685.
12. Wang Y, Leung FC. An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics 2004; 20:1170-7; PMID:14764558; DOI:10.1093/bioinformatics/bth059.
13. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6-21; PMID:11782440; DOI:10.1101/gad.947102.
14. Hennessy BT, Coleman RL, Markman M. Ovarian cancer. Lancet 2009; 374:1371-82; PMID:19793610; DOI:10.1016/S0140-6736(09)61338-6.
15. Balch C, Huang TH, Brown R, Nephew KP. The epigenetics of ovarian cancer drug resistance and resensitization. Am J Obstet Gynecol 2004; 191:1552-72; PMID:15547525; DOI:10.1016/j.ajog.2004.05.025.
16. Baylin SB. Resistance, epigenetics and the cancer ecosystem. Nat Med 2011; 17:288-9; PMID:21383739; DOI:10.1038/nm0311-288.
17. Rodriguez-Paredes M, Esteller M. Cancer epigenetics reaches mainstream oncology. Nat Med 2011; 17:330-9; PMID:21386836; DOI:10.1038/nm.2305.
18. Kristensen LS, Nielsen HM, Hansen LL. Epigenetics and cancer treatment. Eur J Pharmacol 2009; 625:131-42; PMID:19836388; DOI:10.1016/j.ejphar.2009.10.011.
19. Watson JA, Watson CJ, McCrohan AM, Woodfine K, Tosetto M, McDaid J, et al. Generation of an epigenetic signature by chronic hypoxia in prostate cells. Hum Mol Genet 2009; 18:3594-604; PMID:19584087; DOI:10.1093/hmg/ddp307.
20. Wang PH, Lee WL, Juang CM, Yang YH, Lo WH, Lai CR, et al. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol 2005; 99:631-9; PMID:16112178; DOI:10.1016/j.ygyno.2005.07.016.
21. Stanley P, Schachter H, Taniguchi N. N-Glycans. Essentials of Glycobiology New York: Varki A, Cummings R, Esko J, et al. (Eds.) Cold Spring Harbour Laboratory Press 2008; 2:201.
22. Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem 2008; 143:725-9; PMID:18218651; DOI:10.1093/jb/mvn011.
23. Moriwaki K, Narisada M, Imai T, Shinzaki S, Miyoshi E. The effect of epigenetic regulation of fucosylation on TRAIL-induced apoptosis. Glycoconj J 2010; 27:649-59; PMID:20953699; DOI:10.1007/s10719-010-9310-5.
24. Moriwaki K, Noda K, Furukawa Y, Ohshima K, Uchiyama A, Nakagawa T, et al. Deficiency of GMDS leads to escape from NK cell-mediated tumor surveillance through modulation of TRAIL signaling. Gastroenterology 2009; 137:188-98; PMID:19361506; DOI:10.1053/j.gastro.2009.04.002.
25. Peracaula R, Barrabes S, Sarrats A, Rudd PM, de Llorens R. Altered glycosylation in tumours focused to cancer diagnosis. Dis Markers 2008; 25:207-18; PMID:19126965.
26. Moriwaki K, Miyoshi E. Fucosylation and gastrointestinal cancer. World J Hepatol 2010; 2:151-61; PMID:21160988; DOI:10.4254/wjh.v2.i4.151.
27. Moriwaki K, Noda K, Nakagawa T, Asahi M, Yoshihara H, Taniguchi N, et al. A high expression of GDPfucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation. Glycobiology 2007; 17:1311-20; PMID:17884843; DOI:10.1093/glycob/cwm094.
28. Smith PL, Myers JT, Rogers CE, Zhou L, Petryniak B, Becker DJ, et al. Conditional control of selectin ligand expression and global fucosylation events in mice with a targeted mutation at the FX locus. J Cell Biol 2002; 158:801-15; PMID:12186857; DOI:10.1083/jcb.200203125.
29. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987; 236:582-5; PMID:2953071; DOI:10.1126/science.2953071.
30. Xu X, Nagarajan H, Lewis NE, Pan S, Cai Z, Liu X, et al. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol 2011; 29:735-41; PMID:21804562; DOI:10.1038/nbt.1932.
31. Kitazume S, Oka R, Ogawa K, Futakawa S, Hagiwara Y, Takikawa H, et al. Molecular insights into betagalactoside alpha2,6-sialyltransferase secretion in vivo. Glycobiology 2009; 19:479-87; PMID:19150807; DOI:10.1093/glycob/cwp003.
32. Crocker PR. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling. Curr Opin Struct Biol 2002; 12:609-15; PMID:12464312; DOI:10.1016/S0959-440X(02)00375-5.
33. Handerson T, Camp R, Harigopal M, Rimm D, Pawelek J. Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. Clin Cancer Res 2005; 11:2969-73; PMID:15837749; DOI:10.1158/1078-0432.CCR-04-2211.
34. Handerson T, Pawelek JM. Beta1,6-branched oligosaccharides and coarse vesicles: a common, pervasive phenotype in melanoma and other human cancers. Cancer Res 2003; 63:5363-9; PMID:14500369.
35. Chakraborty AK, Sousa Jde F, Chakraborty D, Funasaka Y, Bhattacharya M, Chatterjee A, et al. GnT-V expression and metastatic phenotypes in macrophage-melanoma fusion hybrids is downregulated by 5-Aza-dC: evidence for methylation sensitive, extragenic regulation of GnT-V transcription. Gene 2006; 374:166-73; PMID:16556489; DOI:10.1016/j.gene.2006.01.031.
36. Royle L, Radcliffe CM, Dwek RA, Rudd PM. Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol 2006; 347:125-43; PMID:17072008.
37. Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem 1995; 230:229-38; PMID:7503412; DOI:10.1006/abio.1995.1468.
38. Guile GR, Rudd PM, Wing DR, Prime SB, Dwek RA. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem 1996; 240:210-26; PMID:8811911; DOI:10.1006/abio.1996.0351.
39. Harvey DJ, Royle L, Radcliffe CM, Rudd PM, Dwek RA. Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem 2008; 376:44-60; PMID:18294950; DOI:10.1016/j.ab.2008.01.025.